A group of AML patient cells highly susceptible to UNBS1450 (Pt no. 4, 5, 8, 11 and 19) generally present a reduced level of Bcl-xL and high expression levels of Mcl-1 32 kDa. This evidence concerns the gene MCL1 and acute myeloid leukemia.